Ladenburg Thalmann Financial Services’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-25
| Closed | – | – | 5535 |
|
|
2018
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 5225 |
|
|
2018
Q1 | $0 | Sell |
25
-400
| -94% | -$7.85K | ﹤0.01% | 5315 |
|
|
2017
Q4 | $7K | Hold |
425
| – | – | ﹤0.01% | 4421 |
|
|
2017
Q3 | $9K | Sell |
425
-75
| -15% | -$1.43K | ﹤0.01% | 4159 |
|
|
2017
Q2 | $8K | Hold |
500
| – | – | ﹤0.01% | 4166 |
|
|
2017
Q1 | $6K | Hold |
500
| – | – | ﹤0.01% | 4270 |
|
|
2016
Q4 | $6K | Hold |
500
| – | – | ﹤0.01% | 4184 |
|
|
2016
Q3 | $11K | Hold |
500
| – | – | ﹤0.01% | 3782 |
|
|
2016
Q2 | $15K | Buy |
500
+425
| +567% | +$13.9K | ﹤0.01% | 3539 |
|
|
2016
Q1 | $2K | Hold |
75
| – | – | ﹤0.01% | 4444 |
|
|
2015
Q4 | $3K | Sell |
75
-110
| -59% | -$4.39K | ﹤0.01% | 4295 |
|
|
2015
Q3 | $7K | Hold |
185
| – | – | ﹤0.01% | 3793 |
|
|
2015
Q2 | $8K | Hold |
185
| – | – | ﹤0.01% | 3854 |
|
|
2015
Q1 | $9K | Buy |
185
+75
| +68% | +$2.98K | ﹤0.01% | 3725 |
|
|
2014
Q4 | $3K | Hold |
110
| – | – | ﹤0.01% | 3975 |
|
|
2014
Q3 | $3K | Hold |
110
| – | – | ﹤0.01% | 3617 |
|
|
2014
Q2 | $3K | Hold |
110
| – | – | ﹤0.01% | 3578 |
|
|
2014
Q1 | $3K | Hold |
110
| – | – | ﹤0.01% | 3455 |
|
|
2013
Q4 | $3K | Hold |
110
| – | – | ﹤0.01% | 3456 |
|
|
2013
Q3 | $2K | Hold |
110
| – | – | ﹤0.01% | 3499 |
|
|
2013
Q2 | $2K | Buy |
+110
| New | +$1.95K | ﹤0.01% | 3383 |
|
Ladenburg Thalmann Financial Services's IPXL Position: Q3 2018 in Review
Ladenburg Thalmann Financial Services sold out of Impax Laboratories, Inc. (IPXL) in Q3 2018, closing a stake of 25 shares.
Ladenburg Thalmann Financial Services first reported a position in IPXL in Q2 2013 and held it in 21 quarters. The position peaked at $15K in Q2 2016. 0 funds tracked by Wall St. Rank hold IPXL as of Q3 2018.
- Ladenburg Thalmann Financial Services reported no remaining Impax Laboratories, Inc. position as of Q3 2018 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 25 Impax Laboratories, Inc. shares in Q3 2018.
- Ladenburg Thalmann Financial Services first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 21 quarters.
- Ladenburg Thalmann Financial Services's Impax Laboratories, Inc. position peaked at $15K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2018.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.